MetaCap

GridAI Technologies Corp. (GRDX)

NASDAQ: GRDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.16-0.29 (-8.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GRDX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$32.44M
EPS (TTM)
-$5.65
52-week range
1.87 – 6.93
Day range
3.12 – 3.56
Volume / Avg
125.15K / 120.78K
Beta
—

52-week range

$1.87$6.93

GRDX stock today

GridAI Technologies (GRDX) closed at $3.16 on Nov 20, down 8.41% (-$0.29), versus the S&P 500's 3.70% decline. Shares are 54.4% below their 52-week high of $6.93, set on Jun 1, 2026 and 69.0% above the 52-week low of $1.87, in the middle of the past year's range. GRDX is down 32.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 20.6%.

GridAI Technologies has posted a net loss over the last twelve months (EPS of -$5.65), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About GridAI Technologies

Company profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Jason David Sawyer
Headquarters
Edinburgh, FL
IPO year
2016

Financial highlights

Full financials

In fiscal 2025, GridAI Technologies generated $36,251 in revenue. GridAI Technologies reported a net loss of $6.4 million, compared with a loss of $18.1 million a year earlier. Gross margin was -1813.6% and operating margin -19540.0%.

GridAI Technologies annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$36.25K————
Growth—————
Net income$-6.39M$-18.06M$-15.79M$-14.63M$-58.54M
EPS (diluted)$-4.16$-15.99$-47.88$-416.94$-1,988.53

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$-0.27 vs —

GRDX news

All GRDX news

GridAI Technologies peers

Health Care sector
GRDX peer companies
CompanyPrice% ChgMarket capCompare
HYFTMindWalk Holdings Corp.0.6844-14.27%$32.56Mvs GRDX
FLNAFilana Therapeutics Inc.0.6413+14.52%$32.26Mvs GRDX
ATNMActinium Pharmaceuticals Inc. (Delaware)1.05-1.87%$33.01Mvs GRDX
VERUVeru Inc.1.94-8.06%$33.08Mvs GRDX
CUECue Biopharma Inc.4.15-7.78%$34.69Mvs GRDX
SERSerina Therapeutics Inc.1.12-6.67%$29.76Mvs GRDX
NXTCNextCure Inc.6.45-4.87%$29.53Mvs GRDX
NNVCNanoViricides Inc.1.14-2.56%$29.13Mvs GRDX

Indexes, lists and sector

GridAI Technologies stock FAQ

What is GridAI Technologies's stock price today?

GRDX last traded at $3.16 as of Nov 20, 4:00 PM EST, down 8.41% on the day. Prices are delayed at least 15 minutes.

Does GridAI Technologies pay a dividend?

No. GridAI Technologies does not currently pay a regular cash dividend.

Who is GridAI Technologies's CEO?

Mr. Jason David Sawyer is the chief executive officer of GridAI Technologies Corp..

Has GRDX ever split its stock?

Yes. The most recent GRDX stock split was a 1-for-3 split on Aug 18, 2025, one of 5 splits on record.

What is the GRDX 52-week high?

The 52-week high for GRDX is $6.93 and the 52-week low is $1.87. The stock is currently 54.4% below its high.

Compare GRDX